HK1203500A1 - 氮化雜環化合物 - Google Patents
氮化雜環化合物Info
- Publication number
- HK1203500A1 HK1203500A1 HK15104072.6A HK15104072A HK1203500A1 HK 1203500 A1 HK1203500 A1 HK 1203500A1 HK 15104072 A HK15104072 A HK 15104072A HK 1203500 A1 HK1203500 A1 HK 1203500A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- heterocyclic compound
- nitrogenated heterocyclic
- nitrogenated
- compound
- heterocyclic
- Prior art date
Links
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012100374 | 2012-04-25 | ||
JP2012283470 | 2012-12-26 | ||
PCT/JP2013/062140 WO2013161913A1 (ja) | 2012-04-25 | 2013-04-24 | 含窒素複素環化合物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1203500A1 true HK1203500A1 (zh) | 2015-10-30 |
Family
ID=49483221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15104072.6A HK1203500A1 (zh) | 2012-04-25 | 2015-04-28 | 氮化雜環化合物 |
Country Status (25)
Country | Link |
---|---|
US (2) | US9469637B2 (zh) |
EP (1) | EP2848618B1 (zh) |
JP (1) | JP6157455B2 (zh) |
KR (1) | KR20150005936A (zh) |
AU (1) | AU2013253516B2 (zh) |
BR (1) | BR112014025711A8 (zh) |
CA (1) | CA2869730A1 (zh) |
CL (1) | CL2014002880A1 (zh) |
CO (1) | CO7141410A2 (zh) |
CR (1) | CR20140537A (zh) |
DO (1) | DOP2014000243A (zh) |
EA (1) | EA029892B1 (zh) |
GE (1) | GEP20166554B (zh) |
HK (1) | HK1203500A1 (zh) |
IL (1) | IL235048B (zh) |
MX (1) | MX361539B (zh) |
MY (1) | MY173949A (zh) |
NZ (1) | NZ631258A (zh) |
PE (1) | PE20142258A1 (zh) |
PH (1) | PH12014502396A1 (zh) |
SG (1) | SG11201406552UA (zh) |
TN (1) | TN2014000416A1 (zh) |
UA (1) | UA115057C2 (zh) |
WO (1) | WO2013161913A1 (zh) |
ZA (1) | ZA201408644B (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20142258A1 (es) | 2012-04-25 | 2015-01-15 | Takeda Pharmaceutical | Compuesto heterociclico nitrogenado |
WO2014010732A1 (ja) | 2012-07-13 | 2014-01-16 | 武田薬品工業株式会社 | 複素環化合物 |
WO2014142255A1 (ja) | 2013-03-14 | 2014-09-18 | 武田薬品工業株式会社 | 複素環化合物 |
EP3018123B1 (en) | 2013-07-03 | 2023-05-10 | Takeda Pharmaceutical Company Limited | Amide compound |
WO2015002231A1 (ja) | 2013-07-03 | 2015-01-08 | 武田薬品工業株式会社 | 複素環化合物 |
EP3026051A4 (en) * | 2013-07-24 | 2017-03-08 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
JPWO2015060368A1 (ja) * | 2013-10-23 | 2017-03-09 | 武田薬品工業株式会社 | 複素環化合物 |
EP3087060B1 (en) | 2013-12-23 | 2020-05-13 | Merck Sharp & Dohme Corp. | Pyrimidone carboxamide compounds as pde2 inhibitors |
JP2017114764A (ja) * | 2014-04-25 | 2017-06-29 | 武田薬品工業株式会社 | 片頭痛治療剤 |
WO2016145614A1 (en) | 2015-03-17 | 2016-09-22 | Merck Sharp & Dohme Corp. | Triazolyl pyrimidinone compounds as pde2 inhibitors |
US10287269B2 (en) | 2015-03-26 | 2019-05-14 | Merck Sharp & Dohme Corp. | Pyrazolyl pyrimidinone compounds as PDE2 inhibitors |
EP3291817B1 (en) | 2015-05-05 | 2019-10-02 | Merck Sharp & Dohme Corp. | Heteroaryl-pyrimidinone compounds as pde2 inhibitors |
WO2016183741A1 (en) | 2015-05-15 | 2016-11-24 | Merck Sharp & Dohme Corp. | Pyrimidinone amide compounds as pde2 inhibitors |
WO2016191935A1 (en) | 2015-05-29 | 2016-12-08 | Merck Sharp & Dohme Corp. | 6-alkyl dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016192083A1 (en) | 2015-06-04 | 2016-12-08 | Merck Sharp & Dohme Corp. | Dihydropyrazolopyrimidinone compounds as pde2 inhibitors |
WO2016209749A1 (en) | 2015-06-25 | 2016-12-29 | Merck Sharp & Dohme Corp. | Substituted pyrazolo/imidazolo bicyclic compounds as pde2 inhibitors |
WO2017000276A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Bicyclic heterocyclic compounds as pde2 inhibitors |
WO2017000277A1 (en) | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
CN111447930A (zh) | 2017-11-23 | 2020-07-24 | 奥斯陆大学医院公司 | 心动过速的治疗 |
WO2019241315A1 (en) | 2018-06-12 | 2019-12-19 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
CN113214172A (zh) * | 2021-04-25 | 2021-08-06 | 西南大学 | 氟康唑中间体还原胺化产物的制备方法 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992001938A1 (en) | 1990-07-20 | 1992-02-06 | City Of Hope | Derivatization of c-terminal proline |
DE4211239C2 (de) | 1992-04-03 | 1995-11-16 | Max Planck Gesellschaft | Arzneimittel gegen Herz-Kreislauf-Erkrankungen |
JPH06145169A (ja) | 1992-09-17 | 1994-05-24 | Nippon Soda Co Ltd | 新規な含窒素5員環化合物、その製造方法及び有害生物防除剤 |
JP3601898B2 (ja) | 1996-02-14 | 2004-12-15 | 俊隆 鍋島 | 薬物依存形成抑制剤 |
JPH11292877A (ja) | 1998-04-09 | 1999-10-26 | Yamanouchi Pharmaceut Co Ltd | 1,4−ジ置換ピリドピラジン誘導体 |
WO2000023091A2 (en) | 1998-10-15 | 2000-04-27 | Bioimage A/S | Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
GB9826174D0 (en) | 1998-11-30 | 1999-01-20 | Celltech Therapeutics Ltd | Chemical compounds |
US7655423B2 (en) | 1999-06-14 | 2010-02-02 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
DE60040299D1 (de) | 1999-06-14 | 2008-10-30 | Ford Henry Health System | Stickstoffmonoxid-donoren zum induzieren von neurogenese |
US7135498B1 (en) | 1999-06-14 | 2006-11-14 | Henry Ford Health System | Nitric oxide donors for inducing neurogenesis |
FR2796947A1 (fr) | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Nouveaux derives 8-carbonyl chromanes, leur preparation et leur utilisation en therapeutique |
AU775102B2 (en) | 1999-09-13 | 2004-07-15 | David M. Swope | Composition and method for decreasing neurologic symptomatology |
EP1307201B1 (de) | 2000-08-01 | 2004-11-24 | Bayer HealthCare AG | Selektive pde 2-inhibitoren als arzneimittel zur verbesserung der wahrnehmung |
US20020119978A1 (en) | 2000-12-05 | 2002-08-29 | Swope David M. | Composition and method for decreasing neurologic symptomatology |
DE10064105A1 (de) | 2000-12-21 | 2002-06-27 | Bayer Ag | Neue Substituierte Imidazotriazinone |
EP1380576B1 (en) | 2001-04-16 | 2009-11-25 | Eisai R&D Management Co., Ltd. | 1h-indazole compounds inhibiting jnk |
CN1638775A (zh) | 2002-01-04 | 2005-07-13 | 亨利福尔德健康组织 | 治疗疾病和损伤用的氧化氮供体 |
DE10224462A1 (de) | 2002-06-03 | 2003-12-11 | Bayer Ag | Verwendung von cGMP stimulierenden Verbindungen |
GB0230045D0 (en) | 2002-12-23 | 2003-01-29 | Glaxo Group Ltd | Compounds |
DE60324449D1 (de) | 2002-10-30 | 2008-12-11 | Via Pharmaceuticals Inc | Inhibitoren der phosphodiesterase der zyklischen n, und deren verwendung in therapie |
EP1597386A1 (en) | 2002-11-13 | 2005-11-23 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
AU2003296393A1 (en) | 2002-12-30 | 2004-07-29 | Eli Lilly And Company | Factor xa inhibitors |
CA2517336A1 (en) | 2003-03-04 | 2004-10-21 | Altana Pharma Ag | Purin-6-one-derivatives |
GB2404658A (en) | 2003-08-07 | 2005-02-09 | Bayer Ag | Quinoxalinone derivatives and their use in the treatment of diseases |
WO2005035534A1 (ja) | 2003-10-08 | 2005-04-21 | Ono Pharmaceutical Co., Ltd. | 複素ビシクロ環および複素トリシクロ環化合物およびその医薬 |
JP2005145840A (ja) | 2003-11-12 | 2005-06-09 | Nippon Soda Co Ltd | 縮合ヘテロ環誘導体及び農園芸用殺菌剤 |
RS50575B (sr) | 2003-12-16 | 2010-05-07 | Pfizer Products Inc. | Pirido(2,3-d)pirimidin-2,4-diamini kao inhibitori pde 2 |
AU2004299277A1 (en) | 2003-12-19 | 2005-06-30 | Glaxo Group Limited | Pyrazolo (3,4-b) pyridine compounds, and their use as phosphodiesterase inhibitors |
JP4719745B2 (ja) | 2004-07-29 | 2011-07-06 | メルク・シャープ・エンド・ドーム・コーポレイション | カリウムチャンネル阻害剤 |
JP5130053B2 (ja) | 2005-01-05 | 2013-01-30 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | トリアゾロフタラジン |
CN101103033B (zh) | 2005-01-05 | 2010-08-04 | 尼科梅德有限责任公司 | 作为pde2抑制剂的三唑并酞嗪 |
WO2007094755A2 (en) | 2005-02-04 | 2007-08-23 | Massachusetts Institute Of Technology | Compositions and methods for modulating cognitive function |
WO2007020521A1 (en) | 2005-08-16 | 2007-02-22 | Pharmacia & Upjohn Company Llc | Pyridoyrazinones as pde-5 inhibitors |
US7998978B2 (en) | 2006-05-01 | 2011-08-16 | Pfizer Inc. | Substituted 2-amino-fused heterocyclic compounds |
TW200815436A (en) | 2006-05-30 | 2008-04-01 | Elbion Ag | 4-amino-pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
TW200817400A (en) | 2006-05-30 | 2008-04-16 | Elbion Ag | Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them |
WO2007146230A2 (en) | 2006-06-14 | 2007-12-21 | Merck & Co., Inc. | Non-nucleoside reverse transcriptase inhibitors |
DE102006048693A1 (de) | 2006-10-14 | 2008-04-17 | Bayer Healthcare Ag | Inhibition der PDE2A |
EP2120938A4 (en) | 2006-12-20 | 2010-12-08 | Merck Sharp & Dohme | IMIDAZOPYRIDINE ANALOGUE AS CB2 RECEPTOR MODULATORS FOR THE TREATMENT OF PAIN, RESPIRATORY AND NON-RESPIRATORY DISEASES |
KR101218926B1 (ko) | 2007-08-22 | 2013-01-04 | 아이알엠 엘엘씨 | 키나제 억제제로서의 5-(4-(할로알콕시)페닐)피리미딘-2-아민 화합물 및 조성물 |
PT2565191E (pt) | 2008-05-14 | 2014-12-04 | Astellas Pharma Inc | Derivados do ácido 4-(indol-7- ilcarbonilaminometil)ciclo-hexanocarboxílico como antagonistas de receptores ep4, úteis no tratamento de insuficiência renal crónica ou de nefropatia diabética |
WO2010054260A1 (en) * | 2008-11-07 | 2010-05-14 | Biotie Therapies Gmbh | Imidazo[5,1-c][1,2,4]benzotriazine derivatives as inhibitors of phosphodiesterases |
WO2010054253A1 (en) | 2008-11-07 | 2010-05-14 | Biotie Therapies Gmbh | Triazine derivatives as inhibitors of phosphodiesterases |
EP2401275B1 (en) | 2009-02-24 | 2013-07-24 | Respiratorius AB | Naphthyridine derivatives having bronchodilating activity |
EP2467382B1 (en) | 2009-08-17 | 2014-06-25 | Merck Sharp & Dohme Corp. | Amino tetrahydro-pyridopyrimidine pde10 inhibitors |
AU2010303567B2 (en) | 2009-10-06 | 2016-06-09 | Millennium Pharmaceuticals, Inc | Heterocyclic compounds useful as PDK1 inhibitors |
WO2011059839A1 (en) | 2009-10-29 | 2011-05-19 | Sirtris Pharmaceuticals, Inc. | Bicyclic pyridines and analogs as sirtuin modulators |
JP5760085B2 (ja) | 2010-08-04 | 2015-08-05 | 武田薬品工業株式会社 | 縮合複素環化合物 |
WO2012042541A2 (en) | 2010-09-30 | 2012-04-05 | Council Of Scientific & Industrial Research | Method for predicting and modeling anti-psychotic activity using virtual screening model |
US8927559B2 (en) | 2010-10-11 | 2015-01-06 | Merck Sharp & Dohme Corp. | Quinazolinone-type compounds as CRTH2 antagonists |
US9265735B2 (en) | 2010-11-30 | 2016-02-23 | New York University | Methods for screening to identify therapeutic agents for Alzheimer's disease and use thereof |
BR112013015397A2 (pt) | 2010-12-23 | 2016-09-20 | Merck Sharp & Dohme | composto, composição farmacêutica, e, uso de um composto |
KR20140040774A (ko) | 2011-05-30 | 2014-04-03 | 아스테라스 세이야쿠 가부시키가이샤 | 이미다조피리딘 화합물 |
EP2723747A1 (en) | 2011-06-22 | 2014-04-30 | Vertex Pharmaceuticals Inc. | Compounds useful as inhibitors of atr kinase |
RU2625787C2 (ru) | 2011-11-03 | 2017-07-19 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Ингибиторы вируса гепатита с, имеющие жесткую вытянутую цепь и содержащие фрагмент { 2-[4-(бифенил-4-ил)-1н-имидазо-2-ил]пирролидин-1-карбонилметил} амина |
PE20142258A1 (es) | 2012-04-25 | 2015-01-15 | Takeda Pharmaceutical | Compuesto heterociclico nitrogenado |
WO2014010732A1 (ja) | 2012-07-13 | 2014-01-16 | 武田薬品工業株式会社 | 複素環化合物 |
EP3026051A4 (en) | 2013-07-24 | 2017-03-08 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
-
2013
- 2013-04-24 PE PE2014001787A patent/PE20142258A1/es not_active Application Discontinuation
- 2013-04-24 MY MYPI2014703159A patent/MY173949A/en unknown
- 2013-04-24 CA CA2869730A patent/CA2869730A1/en not_active Abandoned
- 2013-04-24 BR BR112014025711A patent/BR112014025711A8/pt not_active IP Right Cessation
- 2013-04-24 WO PCT/JP2013/062140 patent/WO2013161913A1/ja active Application Filing
- 2013-04-24 AU AU2013253516A patent/AU2013253516B2/en not_active Ceased
- 2013-04-24 UA UAA201412630A patent/UA115057C2/uk unknown
- 2013-04-24 KR KR20147030296A patent/KR20150005936A/ko not_active Application Discontinuation
- 2013-04-24 JP JP2014512669A patent/JP6157455B2/ja not_active Expired - Fee Related
- 2013-04-24 SG SG11201406552UA patent/SG11201406552UA/en unknown
- 2013-04-24 US US14/397,066 patent/US9469637B2/en not_active Expired - Fee Related
- 2013-04-24 GE GEAP201313643A patent/GEP20166554B/en unknown
- 2013-04-24 EP EP13781872.0A patent/EP2848618B1/en active Active
- 2013-04-24 MX MX2014013011A patent/MX361539B/es active IP Right Grant
- 2013-04-24 NZ NZ631258A patent/NZ631258A/en not_active IP Right Cessation
- 2013-04-24 EA EA201491936A patent/EA029892B1/ru not_active IP Right Cessation
-
2014
- 2014-10-02 TN TN2014000416A patent/TN2014000416A1/fr unknown
- 2014-10-07 IL IL235048A patent/IL235048B/en not_active IP Right Cessation
- 2014-10-24 PH PH12014502396A patent/PH12014502396A1/en unknown
- 2014-10-24 CL CL2014002880A patent/CL2014002880A1/es unknown
- 2014-10-24 DO DO2014000243A patent/DOP2014000243A/es unknown
- 2014-11-24 CR CR20140537A patent/CR20140537A/es unknown
- 2014-11-25 ZA ZA2014/08644A patent/ZA201408644B/en unknown
- 2014-11-25 CO CO14258929A patent/CO7141410A2/es unknown
-
2015
- 2015-04-28 HK HK15104072.6A patent/HK1203500A1/zh not_active IP Right Cessation
-
2016
- 2016-09-13 US US15/264,213 patent/US10017508B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL258280B (en) | Heterocyclic compounds as pesticides | |
HK1203500A1 (zh) | 氮化雜環化合物 | |
HK1210769A1 (zh) | 雜環化合物 | |
EP2889291A4 (en) | HETEROCYCLIC CONNECTION | |
ZA201405045B (en) | Pyrazinecarboxamide compound | |
EP2862853A4 (en) | FUSED HETEROCYCLIC COMPOUND | |
EP2921480A4 (en) | NITROGENIC HETEROCYCLIC COMPOUND | |
EP2865671A4 (en) | CONDENSED HETEROCYCLIC COMPOUND | |
EP2857396A4 (en) | CONDENSED HETEROCYCLIC COMPOUND | |
EP2857397A4 (en) | CONDENSED HETEROCYCLIC COMPOUND | |
EP2842955A4 (en) | TRK-INHIBITING CONNECTION | |
EP2873669A4 (en) | HETEROCYCLIC COMPOUND | |
EP2832734A4 (en) | HETEROCYCLIC CONNECTION | |
HK1202543A1 (zh) | 氮雜環化合物 | |
EP2818473A4 (en) | HETEROCYCLIC COMPOUND | |
EP2709609A4 (en) | HETEROCYCLIC COMPOUNDS | |
EP2927229A4 (en) | HETEROCYCLIC COMPOUND | |
EP2865672A4 (en) | FUSED HETEROCYCLIC COMPOUND | |
EP2857400A4 (en) | HETEROCYCLIC COMPOUND | |
GB201220843D0 (en) | Compound | |
EP2781517A4 (en) | NITROGENATED HETEROCYCLIC COMPOUND | |
HK1215568A1 (zh) | 含氮雜環化合物 | |
GB201216309D0 (en) | Compound | |
GB201215675D0 (en) | Compound | |
EP2840083A4 (en) | NITROGENATED, BICYCLIC, AROMATIC, HETEROCYCLIC COMPOUND |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230420 |